WindStar Medical was acquired by Oakley Capital

WindStar Medical, a Berlin, Germany-based operator of an OTC platform, announced that it was acquied by the private equity firm Oakley Capital.

The deal was made with existing owner ProSiebenSat.1 majority-owned NuCom Group and two minority shareholders, and values the company at €280 million. Since 2016, the company has been part of ProSiebenSat.1 and was reclassified in 2018 under the umbrella of the NuCom Group, which is majority-owned by ProSiebenSat.1 and General Atlantic as a minority investor.

WindStar Medical is an over-the-counter (“OTC”) consumer healthcare company. The platform, which is expected to generate over €120 million in revenues this year, designs, develops and commercialises branded consumer health and private label products, with a track record of establishing best-in-class medical formulations and brands.

The Consumer Brands segment of WindStar Medical offers a wide range of premium high-growth branded products in Germany, including SOS (wound care / disinfectants), Zirkulin (gastro-intestinal care), GreenDoc (mental wellbeing) and EyeMedica (eye health). WindStar Medical is also a provider of Private Label products to the leading German drug stores and supermarkets, whilst also developing an international distribution footprint through existing and new partners.